Antisense modulation of Ship-1 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsC. Frank Bennett, Susan M. Freier
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of Ship-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Ship-1. Methods of using these compounds for modulation of Ship-1 expression and for treatment of diseases associated with expression of Ship-1 are provided.
Claims20
A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding Ship-1, wherein said compound specifically hybridizes with said nucleic acid molecule encoding Ship-1 and inhibits the expression of Ship-1.
A compound 8 to 50 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of an active site on a nucleic acid molecule encoding Ship-1.
Dependencies are inferred from the claim text.